HeartSciences IncHSCS
Price$3.89

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $4.5K+3.9% YoYTTM through 31 Jul 2026
Net Income -$10.3MTTM through 31 Jul 2026
Free Cash Flow -$6.8MTTM through 31 Jul 2026

Margins

Current
Gross Margin57.9%
Operating Margin-89,939.6%
Net Margin-227,024.2%

Returns

-320.2%ROE
-112.4%ROA

Balance Sheet Health

Debt / Equity1.36x
Current Ratio1.16x
Net Debt$205K
Cash & Equivalents$29.9K

Quality Metrics

Altman Z-Score-40.75
Piotroski F-Score3 / 9
FCF Margin-150,381.8%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'22'23'24'25'26
FY2026: $4.3K
Diluted EPS-$6.56TTM
'22'23'24'25'26
FY2026: $-3.48

Dividend

No dividend

Capital Allocation

Capex Intensity78.6%

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.